Indab, Jessa .
HRN: 25-74-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2024
CEFUROXIME 500MG (TAB)
08/25/2024
09/01/2024
PO
500mg Tab
BID
S/P NSVD, Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes